Double-blind cross-over study of the effect of sultosilic-acid pioerazine salt (A-585) and bezafibrate in primary hyperlipoproteinemia
- 1 November 1983
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 49 (2) , 109-118
- https://doi.org/10.1016/0021-9150(83)90188-0
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Accuracy and reproducibility of a quantitative electrophoresis of plasma lipoproteins: interlaboratory comparison and verification by ultracentrifugationClinica Chimica Acta; International Journal of Clinical Chemistry, 1981
- Reduced LDL- and increased HDL-apoproteins in patients with hypercholesterolaemia under treatment with bezafibrateAtherosclerosis, 1981
- One-year study of the effect of bezafibrate on serum lipoprotein concentrations in hyperlipoproteinaemiaAtherosclerosis, 1978
- Dose-response study of bezafibrate on serum lipoprotein concentrations in hyperlipoproteinaemiaAtherosclerosis, 1978
- Plasma lipids in a London population and their relation to other risk factors for coronary heart disease.Heart, 1978
- Association of serum lipids and obesity with cardiovascular mortality.BMJ, 1977
- HDL cholesterol and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study.Circulation, 1977
- High density lipoprotein as a protective factor against coronary heart diseaseThe American Journal of Medicine, 1977
- Abnormal Platelet Function in MyelofibrosisAmerican Journal of Clinical Pathology, 1966
- Immunochemical quantitation of antigens by single radial immunodiffusionImmunochemistry, 1965